Fetal Growth in Multiple Gestations: Evaluation and Management.

Obstet Gynecol Clin North Am

Division of Maternal-Fetal Medicine, University of Colorado, Children's Hospital Colorado, Colorado Fetal Care Center, 12631 East 17th Avenue, Box B198-5, Aurora, CO 80045, USA.

Published: June 2021

Multifetal gestation pregnancies present a clinical challenge due to unique complications including growth issues, prematurity, maternal risk, and pathologic processes, such as selective intrauterine growth restriction (sIUGR), twin-to-twin transfusion syndrome (TTTS), and twin anemia-polycythemia sequence. If sIUGR is found, then management may involve some combination of increased surveillance, fetal procedures, and/or delivery. The combination of sIUGR with TTTS or other comorbidities increases the risk of pregnancy complications. Multifetal pregnancy reduction is an option when a problem is confined to a single fetus or when weighing the risks and benefits of a multifetal gestation in comparison to a singleton pregnancy.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ogc.2021.02.009DOI Listing

Publication Analysis

Top Keywords

multifetal gestation
8
fetal growth
4
growth multiple
4
multiple gestations
4
gestations evaluation
4
evaluation management
4
management multifetal
4
gestation pregnancies
4
pregnancies clinical
4
clinical challenge
4

Similar Publications

Impact of Chorionicity in Neurodevelopmental Outcomes in Preterm Twins.

Cureus

December 2024

Neonatology Department, Maternidade Bissaya Barreto, Unidade Local de Saúde de Coimbra, Coimbra, PRT.

Introduction Multifetal pregnancies, which account for 2-4% of births worldwide, have increased in recent years. Twin pregnancies carry a higher risk of preterm birth and associated neonatal morbimortality, with monochorionic twins considered at greater risk. This study investigates the influence of chorionicity on neurodevelopmental outcomes in preterm twins.

View Article and Find Full Text PDF

Maternal Morbidity and Medically Assisted Reproduction Treatment Types.

Obstet Gynecol

December 2024

Centre for Longitudinal Studies, Social Research Institute, University College London, London, United Kingdom; Population Science, Huntsman Cancer Institute, the Department of Family and Consumer Studies, the Department of Obstetrics and Gynecology, and the Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City; Max Planck Institute for Demographic Research, Rostock, Germany; the Helsinki Institute for Demography and Population Health, University of Helsinki, Helsinki, Finland; and the Max Planck - University of Helsinki Center for Social Inequalities in Population Health, Rostock, Germany and Helsinki, Finland.

Article Synopsis
  • The study aims to analyze the risk of maternal morbidity based on how pregnancies were achieved, focusing on various methods of medically assisted reproduction like fertility drugs, IUI, and ART.
  • Data from Utah's birth certificates (2009-2017) showed that 4.8% of pregnancies were from assisted reproduction, with maternal morbidity defined by complications like blood transfusions and ICU admissions.
  • Results indicated higher maternal morbidity risks for those using assisted reproduction, particularly with ART and autologous oocytes, although these risks decreased when controlling for factors like multiple pregnancies and existing health issues.
View Article and Find Full Text PDF

Objective: We compared processes of antepartum, intrapartum and postpartum care and obstetrical outcomes between physicians and non-physicians.

Design: This is a population-based retrospective matched cohort study.

Setting: The study was conducted in Ontario, Canada.

View Article and Find Full Text PDF

Objective: To explore the personal experiences of women faced with the decision to continue a triplet pregnancy or undergo multifetal pregnancy reduction.

Methods: A qualitative study with semi-structured interviews was conducted between October 2021 and April 2023. Participants included women who continued a triplet pregnancy, and those who underwent multifetal pregnancy reduction from triplet to twins or singletons, 1-6 years post-decision.

View Article and Find Full Text PDF

Placenta accreta spectrum (PAS) presents a significant risk of maternal morbidity and mortality, in large part due to the potential for massive hemorrhage at time of delivery. Recently, multiple gestations have been shown to be an independent risk factor for PAS, especially in the setting of other major risk factors. Importantly, antenatal detection of PAS in twin pregnancies has been shown to be suboptimal when compared to singleton pregnancies.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!